BSLWS - GALLIUM CITRATE GA-67 INJECTION

  • MSDS: BSLWS
  • Manufacturer: MALLINCKRODT INC
  • Product Name: GALLIUM CITRATE GA-67 INJECTION
  • National Stock Number: 6505-00F030804
Product Identification

Product ID:GALLIUM CITRATE GA-67 INJECTION
MSDS Date:11/18/1985
FSC:6505
NIIN:00F030804
MSDS Number: BSLWS

Responsible Party
MALLINCKRODT INC
675 MCDONNELL BLVD
ST. LOUIS, MO 63134
US

Emergency Phone: 314-895-2000/314-982-5000

Info Phone: 314-895-2000

Cage: 37940

Contractor
MALLINCKRODT INC
5840 ST. LOUIS, MO 63134 US

Telephone: 314-539-1600

Cage: 37940

Ingredients

GALLIUM CITRATE *93-3*

CAS: 41183-64-6

Hazards

Routes of Entry: Inhalation:NO Skin:NO Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:INGESTION: MAY CAUSE ASYMPTOMATIC
PHYSIOLOGICAL UPTAKE BY SPECIFIC TARGET ORGANS OR TISSUES. EYES:
MECHANICAL IRRITATION. CHRONIC: HEALTH RISKS ASSOCIATED W/CHRONIC
RADIATION EXPOSURE (CANCER, LEUKEMI A, GENETIC & TERATOGENIC
EFFECTS) INVOLVE LEVELS OF EXPOSURE WHICH ARE MUCH HIGHER THAN
THOSE PERMITTED OCCUPATIONALLY.
Explanation of Carcinogenicity:NONE

First Aid

First Aid:INGESTION: NOTIFY RADIATION SAFETY PERSONNEL IMMEDIATELY. THE
AMOUNT OF MATERIAL SHOULD BE ASSESSED & DOCUMENTED. SKIN: WASH
THOROUGHLY W/SOAP & WATER UNTIL NO MORE RADIOACTIVITY CAN BE
REMOVED. ALWAY S BLOT DRY. DON'T ABRADE SKIN. EYES: FLUSH W/WATER
FOR AT LEAST 15 MINS OR UNTIL NO MORE RADIOACTIVITY CAN BE REMOVED.
OBTAIN MEDICAL ATTENTION IN ALL CASES. (SEE SUPPLEMENTAL
INFORMATION).

Fire Fighting

Extinguishing Media:ANY MEANS SUITABLE FOR SURROUNDING FIRE.
Fire Fighting Procedures:WEAR FULL PROTECTIVE CLOTHING & NIOSH APPROVED
SCBA W/FULL FACEPIECE OPERATED IN PRESSURE DEMAND OR OTHER POSITIVE
PRESSURE MODE.

Accidental Release

Spill Release Procedures:IF PRODUCT IS RECEIVED IN A LEAKING CONDITION
OR ANY LOSS OR RELEASE OF THE RADIOACTIVE CONTENTS OCCURS, NOTIFY
RADIATION SAFETY DEPARTMENT & MALLINCKRODT.

Handling

Handling and Storage Precautions:RADIOACTIVE DRUGS MUST BE HANDLED BY
QUALIFIED PERSONNEL. THE VIAL CONTAINING THE DRUG SHOULD BE KEPT
WITHIN ITS CONTAINER/HEAVIER SHIELDING.
Other Precautions:AVOID CONTACT W/RADIOACTIVE CONTENTS WHICH WOULD
CAUSE UNNECESSARY EXPOSURE TO RADIATION. STORE AT ROOM TEMPERATURE.
HANDLING DEVICES SUCH AS SYRINGE SHIELDS & TONGS SHOULD BE USED. NO
SMOKING, EATING , DRINKING SHOULD BE ALLOWED IN AREA.

Exposure Controls

Protective Gloves:DISPOSABLE PLASTIC, LATEX, RUBBER
Eye Protection:SAFETY GLASSES
Other Protective Equipment:LABCOAT
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE.
Supplemental Safety and Health
TOXICITY DATA: SUFFICIENT QUANTITIES OF IONIZING RADIATION CAN
POTENTIALLY CAUSE HARMFUL BIOLOGICAL EFFECTS. CURIE QUANTITIES
INJECTED INTO BODY MAY CAUSE ACUTE RADIATION SICKNESS.
CONCENTRATION: 2 MC I/ML AS OF THE CALIBRATION DATE. SPECIFIC
ACTIVITY: 2 MCI/8.3 NANOGRAMS OF GALLIUM. HALF LIFE: 78.26 HOURS.

Chemical Properties

Boiling Pt:B.P. Text:212F
Melt/Freeze Pt:M.P/F.P Text:32F
Solubility in Water:COMPLETE
Appearance and Odor:CLEAR, COLORLESS LIQUID, ODORLESS

Stability

Stability Indicator/Materials to Avoid:YES
Hazardous Decomposition Products:RADIOACTIVE FUMES CONTAINING GALLIUM

Disposal

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE W/LOCAL, STATE, &
FEDERAL REGULATIONS. RADIOACTIVE WASTE.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.